1.00 / AMA PRA Category 1 CreditsTM 1.00 / CE for Nurse Practitioners
Jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®)
Supported by an educational grant from Novartis Pharmaceuticals Corporation
During this Medical Crossfire, expert faculty will engage in a multidisciplinary roundtable discussion that includes a dermatologist, a rheumatologist, a primary care professional, and a patient advocate to discuss how to best optimize and individualize psoriatic arthritis (PsA) management. Despite the substantial progress made in the understanding and treatment of PsA in recent years, numerous published studies indicate that there are many practice gaps and barriers in the management of PsA. This videotaped expert panel discussion covers factors that differentiate cutaneous and musculoskeletal inflammatory disease in PsA. Covered topics include identifying and classifyinq PsA, treatment approaches, comorbidity, quality of life, and the value of cooperative management between dermatologists; rheumatologists; specialty NPs, PAs, and nurses; and patients. This activity provides key guidance for diagnosing and treating psoriatic arthritis, promoting the collaborative care between dermatologists, rheumatologists, and primary care providers in order to not only keep patients’ needs at the heart, but to include them as a member of the multidisciplinary team and involve them in the decision-making process.
Primary care providers, dermatologists, allergists, nurse practitioners, nurses, physician assistants, and other healthcare professionals involved in the care of patients with PsA
At the conclusion of this activity, participants should be better able to:
Evaluate screening and diagnostic tools for the early identification of individuals with PsA
Describe how to incorporate strategies for early evaluation of patients with psoriasis and joint involvement
Select appropriate therapy for patients with PsA to minimize disease progression, improve patient adherence to therapy, and enhance patient quality of life
Explain how to implement strategies to improve communication and decision-making with patients with PsA
Describe the benefits of optimizing interdisciplinary exchanges in the care of patients with psoriatic arthritis
Disclosure of Conflicts of Interest Policy
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Peter Salgo, MD Professor of Medicine and Anesthesiology Columbia University College of Physicians and Surgeons New York, NY
Dr. Salgo has no relevant financial relationships with commercial interests to disclose.
Alan Menter, MD Chair, Department of Dermatology Baylor University Medical Center Dallas, TX
Dr. Menter discloses the following: Advisory Board: AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli Lilly and Janssen Biotech, Inc., LEO Pharma Consultant: AbbVie, Allergan, Amgen, Eli Lilly, Janssen Biotech, Inc., LEO Pharma, Novartis and Pfizer Investigator AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Eli Lilly, Janssen Biotech, Inc., LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron and Syntrix. Speaker: AbbVie, Amgen, Janssen Biotech, Inc. and LEO Pharma.
Alexis Ogdie, MD, MSCE Assistant Professor of Medicine & Epidemiology Perelman School of Medicine University of Pennsylvania Philadelphia, PA
Dr. Ogdie has the following relevant financial relationships with commercial interest to disclose: Consultant/Independent Contractor: Pfizer, Novartis, and Takeda Grant/Research Support: Pfizer (to the Trustees of the University of Pennsylvania)
Ty Westfall Psoriasis Patient Advocate Allen, TX
Mr. Westfall has no relevant financial relationships with commercial interests to disclose.
Accredited Provider Disclosure
Global Education Group Planning Staff: Ashley Marostica, RN, MSN, Lindsay Borvansky, Kristen Delisi, NP, Amanda Glazar, PhD, Andrea Funk, and Laura Gilsdorf have no relevant financial relationships with commercial interests to disclose.
Publishing Staff Disclosures
Physicians' Education Resource®, LLC (PER®) Planning Staff: David Heckard, Maryjo Dixon, RPh, Jyoti Arya, RPh, and Kathleen Bowen have no relevant financial relationships with commercial interests to disclose.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurse Practitioners
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024
This activity is accredited for 1.00 contact hour which includes 0.00 hour(s) of pharmacology.
Activity ID #2305E
This activity was planned in accordance with AANP CE Standards and Policies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Global Education Group or Pharmacy Times Continuing Education. This material is prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter.
Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.